Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
FANCD2
REST API REST API
Homo sapiens
FANCD2 is differentially expressed in 192 experiments: 93 organism parts: bone marrow, cerebellum, ... (91 more);, 85 disease states: normal, breast carcinoma, ... (83 more);, 80 cell types 222 cell lines 22 compound treatments and 56 other conditions.
Synonyms FACD, FANCD, FAD, FA-D2
Orthologs fancd2 (Danio rerio)   Fancd2 (Rattus norvegicus)   ENSCING00000009065 (Ciona intestinalis)   Fancd2 (Mus musculus)   FANCD2 (Gallus gallus)   FANCD2 (Bos taurus)   Fancd2 (Drosophila melanogaster)   fancd2 (Xenopus laevis)   FANCD2 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term protein binding, DNA repair, gamete generation, cell cycle, nucleus, synapsis, nucleoplasm, response to DNA damage stimulus, response to gamma radiation, condensed chromosome
UniProt Accession Q9BXW9, F8WE37
Gene-Disease Assocation FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2, FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
Search EB-eye ENSG00000144554
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-GEOD-6919, E-TABM-130, ... (16 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-22152, E-GEOD-14464, E-GEOD-19639, E-GEOD-24147, ... (22 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-19639, E-GEOD-20081, E-GEOD-5823
SW982
1
E-MTAB-37
HCT8
1
E-MTAB-37
647V
1
1
E-MTAB-37
HCC2218
1
E-MTAB-37
HCC1143
1
E-MTAB-37
216 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-20677, E-GEOD-13909, E-GEOD-4219, E-GEOD-13987, ... (34 experiments)

Factor Value U/D Experiments
induced pluripotent stem cell
2
E-GEOD-18147, E-GEOD-18265
human embryonic stem cell
1
2
E-GEOD-20033, E-GEOD-18265, E-GEOD-18147
CD34+CD38-/lowCD19+ cell
1
E-MEXP-1403
immortalized cell culture
1
E-GEOD-14990
activated natural killer cell (supplemented for IL2 for 8 hours)
1
E-TABM-702
monolayer
1
E-GEOD-4219
74 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-MEXP-1121, E-GEOD-5563, ... (39 experiments)

Factor Value U/D Experiments
pancreatic carcinoma
2
E-MTAB-37, E-MEXP-1121
adrenocortical carcinoma
2
E-TABM-311, E-GEOD-10927
prostate carcinoma
2
E-MEXP-2034, E-GEOD-7307
acute quadriplegic myopathy
1
E-GEOD-3307
cervical carcinoma
1
E-MTAB-37
NDV
1
E-GEOD-18791
79 more value(s).


Compound treatment

studied in E-MEXP-1601, E-GEOD-3284, E-MEXP-2218, E-GEOD-3202, E-TABM-782, ... (12 experiments)

Factor Value U/D Experiments
none
2
4
E-GEOD-4600, E-TABM-782, E-GEOD-7307, E-MEXP-1958, E-MEXP-1601, ... (6 experiments)
lipopolysaccharide
1
E-MEXP-1958
unknown
1
E-GEOD-7307
CNOT7+CNOT8
1
1
E-MEXP-2218
TTA
1
E-MEXP-2590
AMP
1
1
E-MEXP-2285
16 more value(s).


Age at diagnosis

studied in E-GEOD-21653

Factor Value U/D Experiments
61
2
1
E-GEOD-21653


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-20499, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MEXP-2359, E-GEOD-2666, E-GEOD-4667 ... (5 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-MTAB-69, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643

Erbb2
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-3494, E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-GEOD-7011, E-MTAB-73, E-MEXP-1482, E-GEOD-17385, ... (9 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-3494, E-GEOD-17476, E-TABM-868, E-TABM-601, ... (6 experiments)

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-MEXP-2657, E-GEOD-20540, E-GEOD-20504, E-GEOD-19018, E-GEOD-9764, ... (8 experiments)

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-1290, E-MEXP-2069, E-TABM-666, ... (22 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-1460, E-GEOD-17636, E-GEOD-4600, E-MEXP-1403 ... (5 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-18791, E-GEOD-10896

RNAi
studied in E-MEXP-1857, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Test result
studied in E-TABM-276, E-GEOD-2748

Treatment
studied in E-GEOD-22152, E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-19136, ... (7 experiments)

Tumor grading
studied in E-GEOD-4290, E-GEOD-3494, E-GEOD-22541, E-GEOD-6532, E-GEOD-4922 ... (5 experiments)

Processing time: 0.277 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM